Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor γ and mediated by inhibition of translation initiation

Cancer Research

Volumn 61, Issue 16, 2001, Pages 6213-6218

  Palakurthi, S S ^a   Aktas, H ^a   Grubissich, L M ^a   Mortensen, R M ^a   Halperin, J A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTINEOPLASTIC AGENT; CIGLITAZONE; CYCLINE; DNA; INITIATION FACTOR 2; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE; THIAZOLIDINE DERIVATIVE; TROGLITAZONE; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; INSULIN SENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSLATION INITIATION; TRANSLATION REGULATION; TUMOR GROWTH;

3T3 CELLS; ANIMALS; ANTINEOPLASTIC AGENTS; CALCIUM; CELL DIVISION; CYCLINS; DNA, NEOPLASM; EUKARYOTIC INITIATION FACTOR-2; HUMANS; LIGANDS; MALE; MICE; MICE, INBRED DBA; NEOPLASMS, EXPERIMENTAL; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0035881317     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid- activated transcription factor
2. PPARγ is required for the differentiation of adipose tissue in vivo and in vitro
3. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
4. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor
5. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-γ agonists through induction of apoptosis
6. Ligands for peroxisome proliferator-activated receptor γ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice
7. Peroxisome proliferator-activated receptor γ induces growth arrest and differentiation markers of human colon cancer cells
8. Ligand for peroxisome proliferator-activated receptor γ (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo
9. Effects of troglitazone on the growth and differentiation of hematopoietic cell lines
10. PAX8-PPARγ1 fusion oncogene in human thyroid carcinoma
11. Loss-of-function mutations in PPARγ associated with human colon cancer
12. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcoma
13. Terminal differentiation of human breast cancer through PPARγ
14. Differentiation and reversal of malignant changes in colon cancer through PPARγ
15. Peroxisome proliferator-activated receptor γ ligands inhibit retinoblastoma phosphorylation and G1→S transition in vascular smooth muscle cells
16. Role of PPARγ in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis
17. PPARγ induces cell cycle withdrawal: Inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A
18. Simultaneous Cre catalyzed recombination of two alleles to restore neomycin sensitivity and facilitate homozygous mutations
19. Production of homozygous mutant ES cells with a single targeting construct
20. 2+ stores, phosphorylation of eIF2α and sustained inhibition of translation initiation mediate the anticancer effects of clotrimazole
21. Inhibition of translation initiation mediates the anticancer effect of the n-3 polyunsaturated fatty acid eicosapentaenoic acid
22. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines
23. Clotrimazole inhibits cell proliferation in vitro and in vivo
24. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E
25. 2+ in flux
26. Troglitazone suppresses cell growth of myeloid leukemia cell lines by induction of p21WAF1/CIP1 cyclin-dependent kinase inhibitor
27. The role of PPAR-γ in macrophage differentiation and cholesterol uptake
28. Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells
29. Regulation of translational initiation during cellular responses to stress
30. 2+ entry in endothelial cells
31. Induction of peroxisome proliferator-activated receptor γ during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPβ, C/EBPδ, and glucocorticoids
32. Inhibition of translational initiation by activators of the glucose- regulated stress protein and heat shock protein stress response systems. Role of the interferon-inducible double-stranded RNA-activated eukaryotic initiation factor 2α kinase
33. Features in the 5′ non-coding sequences of rabbit α and β-globin mRNAs that affect translational efficiency
34. Initiation of translation in prokaryotes and eukaryotes
35. Translation factors as effectors of cell growth and tumorigenesis
36. The mRNA 5′ cap-binding protein eIF4E and control of cell growth
37. Inhibition of translational initiation in eukaryotic cells by calcium ionophore
38. Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells
39. Regulation of the interferon-inducible protein kinase PKR and (2′-5′) oligo (adenylate) synthetase by a catalytically inactive PKR mutant through competition for double-stranded RNA binding
40. Mammalian G1 cyclins
41. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age
42. The p21(Cip1) and p27(Kip1) CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts
43. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells
44. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors